In today’s recent session, 0.41 million shares of the Bionano Genomics Inc (NASDAQ:BNGO) have been traded, and its beta is 2.33. Most recently the company’s share price was $0.44, and it changed around -$0.02 or -3.35% from the last close, which brings the market valuation of the company to $30.70M. BNGO at last check was trading at a discount to its 52-week high of $3.01, offering almost -584.09% off that amount. The share price’s 52-week low was $0.31, which indicates that the recent value has risen by an impressive 29.55% since then. We note from Bionano Genomics Inc’s average daily trading volume that its 10-day average is 1.48 million shares, with the 3-month average coming to 1.73 million.
Bionano Genomics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.50. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended BNGO as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Bionano Genomics Inc is expected to report earnings per share of -0.21 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bionano Genomics Inc (NASDAQ:BNGO) trade information
Instantly BNGO has been showing red trend so far today with a performance of -3.35% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4690 on recent trading dayincreased the stock’s daily price by 6.18%. The company’s shares are currently down -76.50% year-to-date, but still down -2.14% over the last five days. On the other hand, Bionano Genomics Inc (NASDAQ:BNGO) is 0.20% up in the 30-day period. We can see from the shorts that 4.16 million shares have been sold at a short interest cover period of 3.03 day(s).
The consensus price target as assigned by Wall Street analysts is $2, which translates to bulls needing to increase their stock price by 78.0% from its current value. Analyst projections state that BNGO is forecast to be at a low of $1 and a high of $175.
Bionano Genomics Inc (BNGO) estimates and forecasts
Bionano Genomics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -58.09 percent over the past six months and at a 71.99% annual growth rate that is well above the industry average of 17.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 93.50% in revenue this quarter, and will report an increase of 63.40% in the next quarter. The year-over-year growth rate is expected to be -2.00%, down from the previous year.
Consensus estimates provided by 4 financial analysts predict the company will bring in an average of 7.85M in revenue for the current quarter. 4 analysts expect Bionano Genomics Inc to make 10.98M in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at 2.40%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 23.59%.
BNGO Dividends
Bionano Genomics Inc’s next quarterly earnings report is expected to be released on 2024-Nov-06.
Bionano Genomics Inc (NASDAQ:BNGO)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.14% of Bionano Genomics Inc shares, and 11.76% of them are in the hands of institutional investors. The stock currently has a share float of 11.78%.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Jun 30, 2024. The former held 1.36 shares worth $0.61 million, making up 1.59% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 505.29 shares worth around $0.22 million, which represents about 0.59% of the total shares outstanding.
